A Review of the Use of Native and Engineered Probiotics for Colorectal Cancer Therapy

Abstract

Colorectal cancer (CRC) is a serious global health concern, and researchers have been investigating different strategies to prevent, treat, or support conventional therapies for CRC. This review article comprehensively covers CRC therapy involving wild-type bacteria, including probiotics and oncolytic bacteria as well as genetically modified bacteria. Given the close relationship between CRC and the gut microbiota, it is crucial to compile and present a comprehensive overview of bacterial therapies used in the context of colorectal cancer. It is evident that the use of native and engineered probiotics for colorectal cancer therapy necessitates research focused on enhancing the therapeutic properties of probiotic strains.. Genetically engineered probiotics might be designed to produce particular molecules or to target cancer cells more effectively and cure CRC patients.

Encapsulation of Probiotics within Double/Multiple Layer Beads/Carriers: A Concise Review

“…PROs are naturally considered as functional ingredients due to their wellness-enhancing capabilities [ 13 ]. In this line, PROs have various human health benefits such as the enhancement of intestinal microbial balance, prevention of pathogenic growth through the production of antimicrobial compounds, modulation and control of the innate immune systems, unveiling antimutagenic activities, and stopping/inhibiting cancers [ 14 , 15 , 16 , 17 , 18 ].…”